Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-29

Clinical Trial Update: Delivra Topical Creatine for Improving Muscular Power [NA]

View source ↗

Summary

A completed clinical trial evaluating Delivra Topical Creatine for improving muscular power in individuals with muscle weakness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Delivra Topical Creatine (creatine)

Snippet

Sponsor: University of Saskatchewan | Conditions: Muscle Weakness | NA | Status: COMPLETED